Form 4: Yield10 Bioscience VP Finance Reports Share Transactions

Charles B. Haaser, VP Finance and CAO of Yield10 Bioscience, reports the withholding of shares for tax obligations and acquisition of shares through the company's 401(k) plan.

Summary

• On August 15, 2024, Charles B. Haaser, VP Finance and CAO of Yield10 Bioscience, had shares withheld to cover withholding taxes upon the vesting of RSUs granted on February 15, 2024.
• A total of 731 shares were withheld at a price of $1.5.
• Haaser also acquired 2,143 shares through the Yield10 Bioscience, Inc. 401(k) Plan.
• Following these transactions, Haaser directly owns 5,949 shares and indirectly owns 2,143 shares through the 401(k) plan.
• The share numbers reflect the 1:24 reverse stock split that occurred on May 2, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing primarily reports routine transactions related to tax obligations and 401(k) contributions. It doesn't provide strong positive or negative signals about the company's performance or future prospects.

Positives

• The acquisition of shares through the 401(k) plan indicates confidence in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine insider activity.

Key Dates

Keywords

Yield10 Bioscience, YTEN, Charles Haaser, Form 4, Share Transactions, RSUs, 401(k) Plan, Reverse Stock Split